Study Highlights Potential Risks of Glucosamine for Mild Cognitive Impairment
A new study suggests that glucosamine, a popular supplement commonly used by older adults for joint health, may be linked to a quicker advancement of Alzheimer’s disease in those with mild cognitive impairment.
Researchers from the University of Florida explored how glucosamine influences dementia risk and overall health. They examined medical records of patients with mild cognitive impairment, along with studies on laboratory mice and human brains affected by Alzheimer’s disease. Their findings were published in the journal Nature Metabolism.
The study investigated a process known as glycosylation, where brain cells attach sugar chains to proteins. According to Dr. Ramon Sun, a professor involved in the research, these sugar chains are essential for proteins to function properly in the brain. He explained that in a well-functioning cell, these sugar chains help proteins fold correctly and reach their intended destinations. However, an excess of these chains may hinder proper communication between nerve cells, especially in Alzheimer’s-affected brains.
Glucosamine is naturally found in the body and is made from sugar and amino acids. It’s mainly concentrated in cartilage, which cushions joints. Neil Levin, a nutrition expert, noted that glucosamine supports joint health, which is why many people take it as a supplement.
In the study, the researchers observed thousands of patients with cognitive impairment and dementia, narrowing the focus to those taking glucosamine. They found that while glucosamine use did not increase the risk of death in those with mild cognitive impairment, it was associated with a 25% higher likelihood of progressing to dementia. Moreover, patients with existing dementia who used glucosamine faced higher mortality rates compared to those who did not.
To understand the reasons behind these observations, the researchers analyzed brain tissue and noted an abundance of sugar chains in the brains of Alzheimer’s patients. This could interfere with essential communication between nerve cells, similar to how excess wax on a key can prevent it from fitting properly into a lock.
The researchers also conducted experiments with mice, comparing the effects of glucosamine on both healthy brains and those with Alzheimer’s-like symptoms. While healthy mice showed no adverse effects from glucosamine, those with Alzheimer’s-like conditions exhibited increased sugar chains and poorer memory performance when given the supplement.
The study relied on medical records, which may not fully capture all supplements a patient takes. This limitation means the findings signal a need for further controlled studies rather than definitively concluding that glucosamine causes Alzheimer’s disease.
Dr. Sun emphasized the necessity for future clinical trials to thoroughly assess glucosamine’s effects on cognitive decline. It’s important for those with cognitive issues to consult with healthcare professionals about their supplement use, especially if using glucosamine.
In summary, while glucosamine may offer joint support, its implications for brain health in those with cognitive impairment warrant caution. Consulting a doctor can help ensure safe and informed decisions about supplementation.
